Principal Financial Group’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-12,811
| Closed | -$30K | – | 2577 |
|
|
2022
Q3 | $30K | Sell |
12,811
-12,203
| -49% | -$28.6K | ﹤0.01% | 2441 |
|
|
2022
Q2 | $76K | Buy |
25,014
+6,641
| +36% | +$20.2K | ﹤0.01% | 2428 |
|
|
2022
Q1 | $125K | Sell |
18,373
-9,444
| -34% | -$64.3K | ﹤0.01% | 2408 |
|
|
2021
Q4 | $232K | Sell |
27,817
-18,203
| -40% | -$152K | ﹤0.01% | 2318 |
|
|
2021
Q3 | $342K | Sell |
46,020
-1,736
| -4% | -$12.9K | ﹤0.01% | 2272 |
|
|
2021
Q2 | $325K | Buy |
47,756
+10,689
| +29% | +$72.7K | ﹤0.01% | 2334 |
|
|
2021
Q1 | $381K | Buy |
37,067
+2,795
| +8% | +$28.7K | ﹤0.01% | 2216 |
|
|
2020
Q4 | $240K | Buy |
34,272
+2,337
| +7% | +$16.4K | ﹤0.01% | 2277 |
|
|
2020
Q3 | $261K | Buy |
31,935
+15,123
| +90% | +$124K | ﹤0.01% | 2152 |
|
|
2020
Q2 | $116K | Buy |
+16,812
| New | +$116K | ﹤0.01% | 2238 |
|